These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31928345)

  • 61. Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: Pharmacological and in vitro cytotoxicity studies.
    Gadhave D; Rasal N; Sonawane R; Sekar M; Kokare C
    Int J Biol Macromol; 2021 Jan; 167():906-920. PubMed ID: 33186648
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fluoride loaded polymeric nanoparticles for dental delivery.
    Nguyen S; Escudero C; Sediqi N; Smistad G; Hiorth M
    Eur J Pharm Sci; 2017 Jun; 104():326-334. PubMed ID: 28392494
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals.
    Neves AR; Martins S; Segundo MA; Reis S
    Nutrients; 2016 Mar; 8(3):131. PubMed ID: 26950147
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gated Mesoporous Silica Nanocarriers for a "Two-Step" Targeted System to Colonic Tissue.
    González-Alvarez M; Coll C; Gonzalez-Alvarez I; Giménez C; Aznar E; Martínez-Bisbal MC; Lozoya-Agulló I; Bermejo M; Martínez-Máñez R; Sancenón F
    Mol Pharm; 2017 Dec; 14(12):4442-4453. PubMed ID: 29064714
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations.
    Das S; Ng KY; Ho PC
    J Drug Target; 2011 Jul; 19(6):446-57. PubMed ID: 20684731
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
    Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficient Colonic Delivery of DsiRNA by Pectin-Coated Polyelectrolyte Complex Nanoparticles: Preparation, Characterization and Improved Gastric Survivability.
    Hussain Z; Katas H; Yan SL; Jamaludin D
    Curr Drug Deliv; 2017; 14(7):1016-1027. PubMed ID: 28240178
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery.
    Sgorla D; Lechanteur A; Almeida A; Sousa F; Melo E; Bunhak É; Mainardes R; Khalil N; Cavalcanti O; Sarmento B
    Expert Opin Drug Deliv; 2018 Mar; 15(3):213-222. PubMed ID: 29257904
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of Chitosan-Based pH-Sensitive Polymeric Micelles Containing Curcumin for Colon-Targeted Drug Delivery.
    Woraphatphadung T; Sajomsang W; Rojanarata T; Ngawhirunpat T; Tonglairoum P; Opanasopit P
    AAPS PharmSciTech; 2018 Apr; 19(3):991-1000. PubMed ID: 29110292
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures.
    Akbari A; Lavasanifar A; Wu J
    Acta Biomater; 2017 Dec; 64():249-258. PubMed ID: 29030304
    [TBL] [Abstract][Full Text] [Related]  

  • 71. β-lactoglobulin-pectin Nanoparticle-based Oral Drug Delivery System for Potential Treatment of Colon Cancer.
    Izadi Z; Divsalar A; Saboury AA; Sawyer L
    Chem Biol Drug Des; 2016 Aug; 88(2):209-16. PubMed ID: 26896377
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene.
    Shah P; Rajput SJ
    Drug Dev Ind Pharm; 2019 Apr; 45(4):587-602. PubMed ID: 30633575
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors.
    Lian B; Wu M; Feng Z; Deng Y; Zhong C; Zhao X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):154-165. PubMed ID: 30686050
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Facilitated nanoscale delivery of insulin across intestinal membrane models.
    Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
    Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
    Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of conjugate-by-conjugate structured nanoparticles for oral delivery of docetaxel.
    Ha-Lien Tran P; Wang T; Yang C; Tran TTD; Duan W
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110346. PubMed ID: 31761193
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
    Singh G; Pai RS
    J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability.
    Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
    Eur J Pharm Sci; 2018 Jan; 112():28-37. PubMed ID: 29122712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.